Hypertension Canada is the only national non-profit organization dedicated solely to the prevention and control of hypertension and its complications. Select from the following links to learn more about our:
We work with leading minds across medical and health disciplines to advance research and professional and public education, and with policy makers to ensure Canadians can avoid the potentially deadly complications of hypertension.
Seven and a half million people in Canada, about 1 in 5 adults, live with hypertension. Rising blood pressure over the long term causes atherosclerosis – the main risk for premature death (before the age of 65).
Canada has become a leader in the early detection of high blood pressure, its treatment and overall management. Much of this success has been attributed to the Hypertension Canada Guidelines – a set of clinical practice guidelines which are rigorously reviewed and updated annually, providing health care professionals with the most up-to-date recommendations and guidelines for the detection, treatment and control of hypertension.
Despite recent achievements, 1 in 3 people with hypertension has uncontrolled blood pressure, particularly high-risk patients with diabetes and kidney disease; and almost 1 in 5 people with hypertension is unaware of their condition.
Mission & Vision
Advancing the health of Canadians by enabling the detection, prevention and control of high blood pressure and its complications.
Healthy blood pressure for every Canadian.
Hypertension Canada delivers against mission/vision by striving for excellence in three core service areas:
- Research: Knowledge generation through research and innovation.
- Education: Knowledge translation by turning discovery into practice.
- Government & Stakeholder Relations: Creating supportive environments through healthy public policy and lifestyles.
Board of Directors:
Dr. Ross Tsuyuki is Professor and Chair, Department of Pharmacology in the Faculty of Medicine and Dentistry, University of Alberta. He is also a Professor of Medicine (Cardiology) and Director of EPICORE Centre (a health research coordinating centre) and the Editor-in-Chief of the Canadian Pharmacists Journal. His clinical practice is in the Heart Function Clinic at the Mazankowski Alberta Heart Institute. Having previously served on Hypertension Canada’s Board of Directors, Dr. Tsuyuki was elected in 2019 and appointed Vice-President. He also serves as a Co-Chair of the Education & Implementation Committee and is a member of the Hypertension Canada Guidelines Committee.
Dr. Tsuyuki’s interests are in clinical trials design and execution, hypertension, heart failure, community practice-based research, cardiovascular risk factors, and in the provision of support for clinical researchers through the EPICORE Centre. Dr. Tsuyuki has received several awards for teaching, as well as an appointment as a Fellow of the Canadian Society of Hospital Pharmacists, the American College of Cardiology and the Canadian Academy of Health Sciences. In 2005, he was recognized as the Canadian Pharmacist of the Year by the Canadian Pharmacists Association.
Trevor is a lead tax services partner in the Corporate Tax practice in Toronto and is the national industry tax leader for the Infrastructure and Real Estate Sector. Trevor has over 20 years of professional experience in public practice and provides tax advisory services to Canadian and foreign based clients on matters relating to corporate tax planning, corporate reorganizations, mergers and acquisitions, tax accounting, and tax compliance reporting.
Trevor works with a range of clients, which include infrastructure and real estate funds, REITs, private equity funds, infrastructure and real estate developers, and energy funds on matters relating to corporate structuring, project structuring, bid evaluations and tax modeling. He also advises private sector and government sponsors on P3 project procurement and development. Trevor’s extensive experience in these sectors has included working with government and private sector investors on projects relating to energy, airports, roads and bridges, public transit, hospitals, court houses, correctional facilities, concert
halls, and other similar assets.
Trevor is a Chartered Professional Accountant and his education includes a Master of Taxation, a Master of Business Administration (Finance), and a Bachelor of Science in Biochemistry.
Dr. Shelita Dattani is the Vice President of Pharmacy Affairs at the Neighbourhood Pharmacy Association of Canada and in this role she leads a team advocating for pharmacy’s evidence based role in delivering accessible, high-quality healthcare and building capacity in public health and primary care.
Sheli received her bachelor of science in pharmacy from Northeastern University and her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill. Sheli is a pharmacist with over 20 years’ experience in many sectors of the profession, including community, hospital, academia, industry, group purchasing organizations and professional and pharmacy associations.
Sheli maintains a part-time practice in primary care team based practice, community pharmacy, and remote hospital telepharmacy. Sheli also serves as a lecturer at The Memorial University of Newfoundland and as a guest lecturer at The University of Waterloo in their Doctor of Pharmacy Programs. She is passionate about her continued engagement as a preceptor, teacher and educator and is draws inspiration from her roles supporting students and pharmacists in their professional development. Sheli is committed to contributing to pharmacy’s growing role as an integral health care partner.
Victoria, British Columbia
Ms. Dorothy Morris is a clinical nurse educator in cardiac surgery and coronary care at the Royal Jubilee Hospital, Victoria, British Columbia and Canadian Council of Cardiovascular Nurses (CCCN)’s National director for health promotion and advocacy. Ms. Morris was elected to Hypertension Canada’s Board in 2014.
Ms. Morris has co-authored and teaches a basic arrhythmia interpretation and management course, speaks on a variety of cardiovascular topics and has published a number of articles.
She has given numerous presentations at national and international conferences including the Canadian Association of Gerontology, The International Society of Hypertension and the Canadian Cardiovascular Congress. She contributes to the work of Hypertension Canada and the Canadian Institutes of Health Research / Heart and Stroke Foundation Chair’s Hypertension Advisory Committee.
In 2005, Ms. Morris received the award of excellence for nursing education from the college of registered nurses of British Columbia and the clinical cardiovascular excellence award from CCCN. She has also been the recipient of an award of excellence from Hypertension Canada and award of merit for workplace health innovation from the health employers association of British Columbia.
Ms. Morris has a keen interest in cardiovascular disease risk factors, health advocacy and in continuing nursing education initiatives.
Halifax, Nova Scotia
David currently works both as part-time General Counsel to Acadian Seaplants Limited and part- time Counsel to Irving Shipbuilding providing support for key legal issues. Previously, he was the Vice President and General Counsel at Irving Shipbuilding from 2015 to 2019. From 2001 to 2015, he was a partner in the Halifax office of Stewart McKelvey where he had a broad commercially oriented practice in maritime, construction, energy and natural resources, and environmental law. Before law, David had a career in the army as an artillery officer. He continued to serve in the Army Reserve while practicing law and after returning from a tour in Afghanistan in 2010 was invested as a member of the Order of Military Merit by the Governor-General. He retired from the Army in 2015 as a Brigadier-General after 30 years of full and part-time service. His last position was Deputy Commander for the 5th Canadian Division, essentially the Army in Atlantic Canada. He has written, presented and published papers and contributed to books on various marine and environment subjects. David is an associate of the Marine Environmental Law Institute and was a member of the part-time faculty at the Schulich School of Law where he taught Fisheries Law from 2004 to 2015. He was a member of the Transportation Appeal Tribunal of Canada from 2010 to 2017. He was appointed Queen’s Counsel in 2017.
Laurie is currently the Corporate Director, Quality, Patient Safety & Experience at Covenant Health, which provides acute and continuing care programs and services across the province of Alberta. Her educational background includes completion of a BSc (Eng), an MBA and a PhD (Business). Following a number of years as an engineer in the oil and gas sector, her MBA led her to a position in healthcare administration. Following completion of my doctoral program at the University of Alberta, Laurie went on to a post-doctoral fellowship at McGill University, focusing on physician practice patterns during both programs. She was subsequently awarded a Harkness Fellowship in Health Policy with The Commonwealth Fund. She has experience in academia, research and healthcare administration.
Strategic Plan 2022-2025
- Be the trusted voice for hypertension and cardiovascular risk.
- Make HC’s website the single, authoritative point of contact for health care professionals and the general public, to get guidance and information about hypertension.
- Build partnerships with like-minded organizations (e.g., Heart and Stroke Foundation, Canadian Cardiovascular Society) such that HC provides all of their hypertension content in return for attribution.
- Obtain baseline data on blood pressure health in Canada and develop a tracking system to monitor trends over time.
Hypertension Canada Awards
The annual awards recognize a distinguished record of substantial contributions by individual or organizations that have increased prevention and/or improved control of blood pressure in Canada. Deadline for nominations – July 31, 2022
Hypertension Innovations Award
The new annual award recognizes a member or organization that implements innovative approaches in knowledge translation and education related to hypertension and/or primary prevention.
- 2022 Call for Nominations for the Hypertension Innovations Award (.pdf)
- Download 2019 Hypertension Innovations Award Recipient (.pdf)
George Fodor Award
The George Fodor Award recognizes a distinguished record of substantial contributions by individuals or organizations that have increased prevention and/or improved control of blood pressure in Canada. Contributions worthy of this prestigious award are expected to be broad in scope (i.e., national) and enduring over time, and to have had a substantive impact.
- 2022 Call for Nominations for the George Fodor Award (.pdf)
- Download 2021 George Fodor Award Recipients (.pdf)
- Download 2020 George Fodor Award Recipient (.pdf)
- Download 2019 George Fodor Award Recipient (.pdf)
- Download 2017 George Fodor Award Recipient (.pdf)
- Download 2014 George Fodor Award Recipient (.pdf)
Distinguished Service Award
The Distinguished Service Award recognizes a long-standing distinguished record of service to Hypertension Canada by an individual. A nominee must have made significant voluntary service contributions to Hypertension Canada and prolonged contributions to the Canadian Hypertension Society, Blood Pressure Canada and/or Hypertension Canada Guidelines over their career.
- 2022 Call for Nominations for the Distinguished Service Award (.pdf)
- Download 2019 Distinguished Service Award Recipient (.pdf)
- Download 2017 Distinguished Service Award Recipient (.pdf)
- Download 2016 Distinguished Service Award Recipient (.pdf)
- Download 2015 Distinguished Service Award Recipient(.pdf)
- Download 2014 Distinguished Service Award Recipient (.pdf)
Senior Investigator Award
The Senior Investigator Award recognizes research in hypertension or blood pressure by an individual. A nominee must have made significant contributions to the advancement and extension of knowledge in basic, clinical, health services or population-based research specifically relating to hypertension or blood pressure.
- 2022 Call for Nominations for the Senior Investigator Award (.pdf)
- Download 2021 Senior Investigator Award Recipient (.pdf)
- Download 2020 Senior Investigator Award Recipient (.pdf)
- Download 2019 Senior Investigator Award Recipient (.pdf)
- Download 2017 Senior Investigator Award Recipient (.pdf)
- Download 2016 Senior Investigator Award Recipient (.pdf)
- Download 2015 Senior Investigator Award Recipient (.pdf)
- Download 2014 Senior Investigator Award Recipients (.pdf)
Jacques de Champlain New Investigator Award
The Jacques de Champlain New Investigator Award recognizes excellence in the field of hypertension or blood pressure research by a new investigator, who has not exceeded a time period of 10 years from the first appointment as an independent investigator. A nominee must have made significant contributions to the advancement and extension of knowledge in basic, clinical, health services or population-based research specifically relating to hypertension or blood pressure.
- 2022 Call for Nominations for the Jacques de Champlain New Investigator Award (.pdf)
- Download 2021 Jacques de Champlain New Investigator Award Recipient (.pdf)
- Download 2020 Jacques de Champlain New Investigator Award Recipient (.pdf)
- Download 2019 Jacques de Champlain New Investigator Award Recipient (.pdf)
- Download 2017 Jacques de Champlain New Investigator Award Recipient (.pdf)
- Download 2014 Jacques de Champlain New Investigator Award Recipient (.pdf)
Certificates of Excellence
Throughout Canada, community, provincial, regional or national initiatives and ongoing programs of high blood pressure prevention and control are instrumental in improving the control of blood pressure. Many of these initiatives are led and contributed to by community-based organizations, individuals and volunteer efforts. These activities are essential to the health of the average Canadian by potentially lowering cardiovascular disease, but are rarely acknowledged. The Certificates of Excellence are presented to these worthy individuals or organizations in recognition of their outstanding efforts and contributions in Canada through increased public awareness, prevention or control of hypertension.
- 2022 Call for Nominations for the Certificate of Excellence Award (.pdf)
- Download 2020 Certificate of Excellence Recipient (.pdf)
- Download 2019 Certificate of Excellence Recipient (.pdf)
- Download 2017 Certificate of Excellence Recipients (.pdf)
- Download 2016 Certificate of Excellence Recipients (.pdf)
- Download 2015 Certificate of Excellence Recipients (.pdf)
- Download 2014 Certificate of Excellence Recipients (.pdf)
The Outstanding Volunteer Award
The Outstanding Volunteer Award is presented to worthy individuals in recognition of their outstanding efforts and contributions to move forward the mission and vision of Hypertension Canada.